Pertussis toxin induces lymphocytosis in rhesus macaques

Journal of Medical Primatology

Volumn 25, Issue 6, 1996, Pages 375-381

  Paul, W ^a   Hinds, H ^a   Yin, Cheng ^a   Salvato, Maria S ^a   Pauza, C David ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Immunomodulatory; Leukocytosis; Nonhuman primate; Pertussis toxin

Indexed keywords

MACACA MULATTA; MURINAE; PRIMATES;

BORDETELLA VIRULENCE FACTOR; PERTUSSIS TOXIN;

ANIMAL; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOSIS; MACACA; NEUTROPHIL;

ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOCYTOSIS; MACACA MULATTA; NEUTROPHILS; PERTUSSIS TOXIN; VIRULENCE FACTORS, BORDETELLA;

EID: 0030325802     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1996.tb00032.x     Document Type: Article

References (21)

1. AHMED-ANSARI A, BRODIE AR, FULTZ PN, ANDERSON DC, SELL KW, MCCLURE HM: Flow microfluorometric analysis of peripheral blood mononuclear cells from nonhuman primates: Correlation of phenotype with immune function. Amer J Primatol 17:107-131, 1989.
2. ANSHER S, THOMPSON W, BRIDGEWATER J, SNOY P: Pertussis toxin-induced alterations of mutine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed. Infect Immun 61:4240-4247, 1993.
3. ANSHER S, THOMPSON W, SNOY P, HABIG W: Role of endotoxin in alterations of hepatic drug metabolism by diptheria and tenanus toxoids and pertussis vaccine adsorbed. Infect Immun 60:3790-3798, 1992.
4. BILLAT C, DELEMER B, CORREZE C, HAYE B: Effects of pertussis toxin on the erythropoietin-stimulated proliferation and differentiation of erythroid-responsive cells. Biol Neonate 60:371-376, 1991.
5. BURNETTE WN, ARCINIEGA JL, MARS VL, BURNS DL: Properties of pertussis toxin B oligomer assembled in vitro form recombinant polypeptides produced by Eschericia coli. Infect Immun 60:2252-2256, 1992.
6. EMBRETSON J, ZUPANCIC M, RIBAS JL, BURKE A, RACZ P, TENNER-RACZ K, HAASE AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359-362, 1993.
7. HUANG CC, CHEN PM, KUO JK, CHIU WH, LIN ST, LIN YC: Experimental whooping cough. New Engl J Med 266:105-111, 1962.
8. HUANG K, IM SY, SAMLOWSKI WE, DAYNES RA: Molecular mechanisms of lymphocyte extravasation. III. The loss of lymphocyte extravasation potential induced by pertussis toxin is not mediated via the activation of protein kinase C. J Immunol 143:229-238, 1989.
9. LOEB DD, SWANSTROM R, EVERITT L, MANCHESTER M, STAMPER SE, HUTCHISON CA: Complete mutagenesis of the HIV-I protease. Nature 340:397-400, 1989.
10. MORSE S, BARRON B: Studies on the leukocytosis and lymphocytosis induced by bordetella pertussis. III. The distribution of transfused lymphocytes in pertussis treated and normal mice. J Exp Med 132:663-672, 1970.
11. MORSE S, RIESTER S: Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. J Exp Med 125:401-408, 1966.
12. MUNOZ JJ: Action of pertussigen (pertussis toxin) on the host immune system. In: Pathogenesis and Immunity in Pertussis. Wardlaw AC, Parton R (eds). New York: John Wiley & Sons, 173-192, 1988.
13. PANTALEO G, GRAZIOSI C, DEMAREST JF, BUTINI L, MONTRONI M, FOX CH, ORENSTEIN JM, KOTLER DP, FAUCI AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-359, 1993.
14. PAUZA CD, HINDS PW, YIN C, MCKECHNIE TS, HINDS SB, SALVATO MS: The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque. J AIDS Hum Retrov, 13:87-95, 1997.
15. RACZ P, TENNER-RACZ K, KAHL C, FELLER A, KERN P, DIETRICH M: The spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complex. Progress in Allergy 37:81-181, 1986.
16. RAI KR, CHANANA AD, CRONKITE EP, JOEL DD, STEVENS JB: Studies on lymphocytes. XVIII. Mechanism of lymphocytosis induced by supernatant fluids of Bordetella pertussis cultures. Blood 38:49-59, 1971.
17. TAMURA M, NOGIMORI K, MURAI S, YAJIMA M, ITO K, KATADA T, UI M, ISHII S: Subunit structure of islet-activating protein, pertussis toxin, in conformity with A-B model. Biochemistry 21:5516-5522, 1982.
18. TAUB R, ROSETT W, ADLER A, MORSE SI: Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J Exp Med 136:1581-1593, 1972.
19. TOMODA T, OGURA H, KURASHIGE T: Immune responses to Bordetella pertussis infection and vaccination. J Infect Dis 163:559-563, 1991.
20. TOYOTA T, KAI Y, KAKIZAKI M, SAKAI A, GOTO Y, YAJIMA M, UI M: Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase I studies). J Exp Med 130:105-116, 1980.
21. UI M: The multiple biological activities of pertussis toxin. In: Pathogenesis and Immunity in Pertussis. Wardlaw AC, Parton R (eds). New York: John Wiley & Sons, 121-145, 1988.